Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine CR in Irritable Bowel Syndrome
NCT00610909Phase 4Completed
- Sponsor
- Duke University
- Start
- Jan 2002
- Primary completion
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Paroxetine CR with Placebo (2 arms). Primary endpoint: Mean composite pain scores at 12 weeks. Started Jan 2002; status: completed.
02
Drugs
paroxetine
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00610909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00610909.